Company
ChinaPublic company, OTC: JHPCYJiangsu Hengrui Pharmaceuticals Co., Ltd. (OTC: JHPCY), Pudongxin, China – FDA Inspections
Inspection records and compliance data for Jiangsu Hengrui Pharmaceuticals Co., Ltd. in Pudongxin. 3 FDA inspections on record, 1 Form 483, 1 warning letter, last inspected April 04, 2025. Publicly traded as OTC: JHPCY.
Company Profile
This profile covers Jiangsu Hengrui Pharmaceuticals Co., Ltd. based in Pudongxin, China.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 2
- Form 483s
- 1
- Warning letters
- 1
First inspected June 2, 2023. Last inspected April 4, 2025.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 4, 2025 | Not classified | Human Drugs | 1266877 |
| January 19, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1233962 |
| June 2, 2023 | Not classified | Human Drugs | 1209987 |
FDA documents
Form 483s (1)
Warning Letters (1)
Other FDA documents (2)
Other regulators (1)
- China NMPA · 3 inspections · last March 20, 2018
People (3)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Stock ticker
JHPCY
Exchange
OTC
Price as of
November 13, 2026
FEI Number
3011603969
Address
1288 Haike Road, Pudongxin, China
Country
China
ID: d8430568-25ba-4cb0-a549-75fa7caf0a45